解毒益气活血方改善严重脓毒症患者免疫功能的机制研究(3)
 |
| 第1页 |
参见附件。
[3] Dellinger RP,Levy MM,Carlet JM,et al.Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock[J].Intensive Care Med,2008,34(1):17-60.
[4] Anas AA, Wiersinga WJ, de Vos AF, et al. Recent insights into the pathogenesis of bacterial sepsis [J]. Neth J Med, 2010, 68(4):147-152.
[5] 徐鹏，顾勤，董丹江，等. 免疫调理对脓毒症合并多脏器功能障碍患者的疗效[J]. 中华急诊医学杂志，2007,16(12)：1239-1242.
[6] 黄顺伟，管向东，陈娟，等. 乌司他丁联合胸腺肽α1改善脓毒症患者免疫功能的作用机制研究[J]. 中国病理生理杂志，2009,25(11)：2168-2172.
[7] 赵丽芸，罗小星，陈镜合，等. 中药复苏饮对严重脓毒症患者免疫功能的影响[J]. 中国中医急诊，2007,16(7)：768-771.
[8] 刘清泉. 对脓毒症中医病机特点及治法的认识[J]. 北京医学，2007,26(4)：198-200.
[9] Dinarello CA. Proinflammatory cytokines [J]. Chest, 2000, 118(2):503-508.
[10] Shimaoka M, Park EJ. Advances in understanding sepsis [J]. Eur J Anaesthesiol Suppl, 2008, 42: 146-153.
[11] Rodriquez A, Rello J, Neira J, et al. Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery [J]. Shock, 2005, 23(4):298-304.
[12] Laupland KB, Kirkpatrick AW, Delaney A. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis [J]. Crit Care Med, 2007, 35(12):2686-2692.
[13] Hotchkiss RS, Tinsley KW, Swanson PE, et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD+4T lymphocytes in humans[J]. J Immunol, 2001, 166(11):6952-6963.
[14] Le Tulzo Y, Pangault C, Gacouin A, et al. Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome [J]. Shock, 2002, 18(6):487-494.
[15] 李志涛，龚裕强、王盛标，等. 脓毒症患者外周血T淋巴细胞亚群变化及临床意义[J]. 南方医科大学学报，2010,30(10)：2249-2251.
您现在查看是摘要介绍页，详见PDF附件(2550kb)。